| Literature DB >> 35934402 |
Lina Wu1, Xinjie Wang2, Chengyuan Wu3, Xizhong Cao4, Taishan Tang4, He Huang5, Xingxu Huang6.
Abstract
Early and accurate diagnosis of SARS-CoV-2 was crucial for COVID-19 control and urgently required ultra-sensitive and rapid detection methods. CRISPR-based detection systems have great potential for rapid SARS-CoV-2 detection, but detecting ultra-low viral loads remains technically challenging. Here, we report an ultrasensitive CRISPR/Cas12a-based electrochemical detection system with an electrochemical biosensor, dubbed CRISPR-SPCE, in which the CRISPR ssDNA reporter was immobilized onto a screen-printed carbon electrode. Electrochemical signals are detected due to CRISPR cleavage, giving enhanced detection sensitivity. CRISPR-SPCE enables ultrasensitive SARS-CoV-2 detection, reaching as few as 0.27 copies μL-1. Moreover, CRISPR-SPCE is also highly specific and inexpensive, providing a fast and simple SARS-CoV-2 assay.Entities:
Keywords: CRISPR/Cas12a; CeO(2) nanorods; Detection; SARS-CoV-2; Screen-printed carbon electrode
Mesh:
Substances:
Year: 2022 PMID: 35934402 PMCID: PMC9249825 DOI: 10.1016/j.aca.2022.340120
Source DB: PubMed Journal: Anal Chim Acta ISSN: 0003-2670 Impact factor: 6.911
Fig. 3Design of specific crRNAs targeting the E gene for SARS-CoV-2 detection.
Scheme 1Schematic illustration of the functional principle of CRISPR-SPCE.
Fig. 1(A) TEM image of PAH dispersed CeO2 nanorods; (B) XPS survey spectrum of the CeO2 nanorods.
Fig. 2(A) Cyclic voltammetry of PAH/Fc-labeled ssDNA modified SPCE biosensor (a) and CeO2/PAH/Fc-labeled ssDNA modified SPCE (b); (B) DPV of modified SPCE before (a) and after incubation without target DNA (b), as well as after incubation with target DNA (c); (C) PAGE analysis of the ssDNA trans-cleavage ability of Cas12a. Lane 1: target DNA + Fc-labeled ssDNA; lane 2: Cas12a + target DNA + Fc-labeled ssDNA; lane 3: crRNA + target DNA + Fc-labeled ssDNA; lane 4: Cas12a + crRNA + Fc-labeled ssDNA; lane 5: Cas12a + crRNA + target DNA + Fc-labeled ssDNA.
Fig. 4Optimization of the detection conditions. Evaluation of the effects of (A) CeO2 concentration; (B) PAH concentration; (C) Fc-labeled ssDNA concentration; (D) Incubation time and (E) Mg2+ concentration; (F) Comparison of signal change with Fc-labeled ssDNA of different lengths.
Fig. 5(A) DPV with different concentrations of target DNA; (B) The linear calibration curve in the range of 2.0 × 10−8 to 5.0 × 10−5 ng μL−1.
Comparison with reported methods for SARS-CoV-2 detection.
| Assays | Target | Limit of detection | Refs. |
|---|---|---|---|
| DNA nanoscaffold-based hybrid chain reaction colorimetric assay | SARS-CoV-2 RNA | 0.96 pM (5.78 × 105 copies μL−1) | [ |
| CRISPR-Cas12a fluorescence detection | N gene | 3 copies μL−1 | [ |
| CRISPR-Cas12a | ORF1ab and N genes | 7 copies μL−1 | [ |
| CRISPR-Cas12a | E and N genes | 10 copies μL−1 | [ |
| CRISPR-Cas13a SHERLOCK | S, N and Orf1ab genes | 42 copies reaction−1 (2.1 copies μL−1) | [ |
| CRISPR-Cas12a LAMP Lateral flow visual detection | N gene | 2 copies μL−1 | [ |
| Paper based electrochemical | SARS-CoV-2 RNA | 6.9 copies μL−1 | [ |
| CRISPR/Cas13a electrochemical biosensor | ORF and S genes | 0.14 copies μL−1 and 0.75 copies μL−1 | [ |
| 4WJ-based electrochemical biosensor | S gene and Orf1ab gene | 2 copies μL−1 and 3 copies μL−1 | [ |
| CRISPR-SPCE | E gene | 0.27 copies μL−1 | This work |
Fig. 6The selectivity of the proposed system in the detection of SARS-CoV-2.